{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via swap agreements",
        "Counterparty risk exposure",
        "Complex underlying index (UBS CMCI Sugar USD TR Index)",
        "No capital protection",
        "Issuer credit risk",
        "Derivative-based product structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is an Open End Tracker Certificate (ETP) linked to the UBS CMCI Sugar USD TR Index, which is a commodity index. The KIID explicitly states that the product is not simple and may be difficult to understand, indicating complexity. The product does not grant ownership rights to the underlying assets and relies on a specified entitlement to a Redemption Amount from the issuer, which is typical of synthetic replication structures. The presence of a multiplier and management fee accruing daily, along with the product being a debt instrument issued by UBS AG, indicates exposure to issuer credit risk and counterparty risk. The product uses derivative instruments inherently as part of its structure (swap agreements are implied by the nature of tracker certificates and the absence of physical replication). The risk indicator is medium-high (5/7), and the product carries significant risks including total loss of capital, early termination risk, and currency risk. There is no capital protection or principal guarantee. The product is not UCITS compliant. The complexity is driven by the synthetic replication method, derivative usage, counterparty exposure, and the complex nature of the underlying commodity index, which involves roll costs and contango/backwardation effects typical of commodity indices. These factors combined make the product complex under MiFID II rules despite the absence of leverage or inverse exposure."
}